BILL H. MCANALLEY, PH.D.

Corporate Board Profile

Tech Score: 0/100

MANNATECH INC

Filing Date	Source Excerpt
2005-05-02	Bill H. McAnalley, Ph.D. joined Mannatech in August 1996 to serve as Mannatech's Director of Research, Development and New Products and in May 1997, began serving as Mannatech's Chief Science Officer. From March 1995 to July 1996, Dr. McAnalley served as a research and development consultant to Mannatech. From March 1987 to February 1995, Dr. McAnalley served as Vice President of Research and Product Development for Carrington Laboratories, Inc. (NASDAQ symbol CARN), a publicly-traded pharmaceutical research, development and manufacturing company, which manufactures Manapol®, a raw material included in the majority of Mannatech's products. Dr. McAnalley received a B.S. degree in Mathematics from Angelo State University in San Angelo, Texas, a Master of Science degree in Chemistry and Biology from New Mexico Highlands University in Las Vegas, New Mexico, and received a Ph.D. in Pharmacology and Toxicology from the University of Texas Health Science Center in Dallas, Texas. Dr. McAnalley obtained his post-doctoral training in Forensic and Clinical Toxicology from the Dallas Institute of Forensic Science, as well as from the Southwestern Medical School Program at Parkland Hospital in Dallas, Texas. Dr. McAnalley is a member of the National Institutes of Health and the National Science Foundation.

Filing Date

Source Excerpt

2005-05-02

Bill H. McAnalley, Ph.D. joined Mannatech in August 1996 to serve as Mannatech's Director of Research, Development and New Products and in May 1997, began serving as Mannatech's Chief Science Officer. From March 1995 to July 1996, Dr. McAnalley served as a research and development consultant to Mannatech. From March 1987 to February 1995, Dr. McAnalley served as Vice President of Research and Product Development for Carrington Laboratories, Inc. (NASDAQ symbol CARN), a publicly-traded pharmaceutical research, development and manufacturing company, which manufactures Manapol®, a raw material included in the majority of Mannatech's products. Dr. McAnalley received a B.S. degree in Mathematics from Angelo State University in San Angelo, Texas, a Master of Science degree in Chemistry and Biology from New Mexico Highlands University in Las Vegas, New Mexico, and received a Ph.D. in Pharmacology and Toxicology from the University of Texas Health Science Center in Dallas, Texas. Dr. McAnalley obtained his post-doctoral training in Forensic and Clinical Toxicology from the Dallas Institute of Forensic Science, as well as from the Southwestern Medical School Program at Parkland Hospital in Dallas, Texas. Dr. McAnalley is a member of the National Institutes of Health and the National Science Foundation.

Data sourced from SEC filings. Last updated: 2026-03-05